FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2807385679> ?p ?o ?g. }

• W2807385679 endingPage "184" @default.
• W2807385679 startingPage "184" @default.
• W2807385679 abstract "Inflammatory breast cancer (IBC) is a rare and aggressive form of breast cancer that is associated with significantly high mortality. In spite of advances in IBC diagnoses, the prognosis is still poor compared to non-IBC. Due to the aggressive nature of the disease, we hypothesize that elevated levels of inflammatory mediators may drive tumorigenesis and metastasis in IBC patients. Utilizing IBC cell models and patient tumor samples, we can detect elevated NF-κB activity and hyperactivation of non-canonical drivers of NF-κB (nuclear factor kappaB)-directed inflammation such as tyrosine phosphorylated receptor-interacting protein kinase 2 (pY RIPK2), when compared to non-IBC cells or patients. Interestingly, elevated RIPK2 activity levels were present in a majority of pre-chemotherapy samples from IBC patients at the time of diagnosis to suggest that patients at diagnosis had molecular activation of NF-κB via RIPK2, a phenomenon we define as “molecular inflammation”. Surprisingly, chemotherapy did cause a significant increase in RIPK2 activity and thus molecular inflammation suggesting that chemotherapy does not resolve the molecular activation of NF-κB via RIPK2. This would impact on the metastatic potential of IBC cells. Indeed, we can demonstrate that RIPK2 activity correlated with advanced tumor, metastasis, and group stage as well as body mass index (BMI) to indicate that RIPK2 might be a useful prognostic marker for IBC and advanced stage breast cancer." @default.
• W2807385679 created "2018-06-13" @default.
• W2807385679 creator A5000409705 @default.
• W2807385679 creator A5047482077 @default.
• W2807385679 creator A5055539104 @default.
• W2807385679 creator A5059931950 @default.
• W2807385679 creator A5075367416 @default.
• W2807385679 creator A5077809403 @default.
• W2807385679 creator A5083346814 @default.
• W2807385679 creator A5085286918 @default.
• W2807385679 date "2018-06-05" @default.
• W2807385679 modified "2023-09-23" @default.
• W2807385679 title "RIPK2: New Elements in Modulating Inflammatory Breast Cancer Pathogenesis" @default.
• W2807385679 cites W1509970002 @default.
• W2807385679 cites W1514059715 @default.
• W2807385679 cites W1794521507 @default.
• W2807385679 cites W183114306 @default.
• W2807385679 cites W1935743463 @default.
• W2807385679 cites W1975870295 @default.
• W2807385679 cites W1985213644 @default.
• W2807385679 cites W1990735654 @default.
• W2807385679 cites W1992693390 @default.
• W2807385679 cites W1993657306 @default.
• W2807385679 cites W1998309234 @default.
• W2807385679 cites W2000813009 @default.
• W2807385679 cites W2001166572 @default.
• W2807385679 cites W2007691970 @default.
• W2807385679 cites W2008623356 @default.
• W2807385679 cites W2014167332 @default.
• W2807385679 cites W2015565459 @default.
• W2807385679 cites W2018940019 @default.
• W2807385679 cites W2028382049 @default.
• W2807385679 cites W2033403762 @default.
• W2807385679 cites W2042328112 @default.
• W2807385679 cites W2055632365 @default.
• W2807385679 cites W2057062376 @default.
• W2807385679 cites W2065443310 @default.
• W2807385679 cites W2068516394 @default.
• W2807385679 cites W2071751547 @default.
• W2807385679 cites W2079923725 @default.
• W2807385679 cites W2079936328 @default.
• W2807385679 cites W2097035469 @default.
• W2807385679 cites W2101332863 @default.
• W2807385679 cites W2102144390 @default.
• W2807385679 cites W2112687290 @default.
• W2807385679 cites W2116161594 @default.
• W2807385679 cites W2118048714 @default.
• W2807385679 cites W2118161327 @default.
• W2807385679 cites W2129102832 @default.
• W2807385679 cites W2130690901 @default.
• W2807385679 cites W2131729327 @default.
• W2807385679 cites W2132434084 @default.
• W2807385679 cites W2134887638 @default.
• W2807385679 cites W2136736147 @default.
• W2807385679 cites W2149829010 @default.
• W2807385679 cites W2152561297 @default.
• W2807385679 cites W2153019398 @default.
• W2807385679 cites W2159827658 @default.
• W2807385679 cites W2160679814 @default.
• W2807385679 cites W2163498571 @default.
• W2807385679 cites W2168760093 @default.
• W2807385679 cites W2172126351 @default.
• W2807385679 cites W2191264255 @default.
• W2807385679 cites W2267762389 @default.
• W2807385679 cites W2274413360 @default.
• W2807385679 cites W2298576674 @default.
• W2807385679 cites W2302524766 @default.
• W2807385679 cites W2323216105 @default.
• W2807385679 cites W2341048222 @default.
• W2807385679 cites W2343992448 @default.
• W2807385679 cites W2345630246 @default.
• W2807385679 cites W2395887422 @default.
• W2807385679 cites W2411039126 @default.
• W2807385679 cites W2418781181 @default.
• W2807385679 cites W2470226595 @default.
• W2807385679 cites W2528213963 @default.
• W2807385679 cites W2594097120 @default.
• W2807385679 cites W2597872842 @default.
• W2807385679 cites W2611943978 @default.
• W2807385679 cites W2734682845 @default.
• W2807385679 cites W2767638648 @default.
• W2807385679 cites W2793255951 @default.
• W2807385679 cites W2951377960 @default.
• W2807385679 cites W3098392 @default.
• W2807385679 doi "https://doi.org/10.3390/cancers10060184" @default.
• W2807385679 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6025367" @default.
• W2807385679 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29874851" @default.
• W2807385679 hasPublicationYear "2018" @default.
• W2807385679 type Work @default.
• W2807385679 sameAs 2807385679 @default.
• W2807385679 citedByCount "21" @default.
• W2807385679 countsByYear W28073856792018 @default.
• W2807385679 countsByYear W28073856792019 @default.
• W2807385679 countsByYear W28073856792020 @default.
• W2807385679 countsByYear W28073856792021 @default.
• W2807385679 countsByYear W28073856792022 @default.
• W2807385679 countsByYear W28073856792023 @default.
• W2807385679 crossrefType "journal-article" @default.

• next